Table 2.
Overall | T1 | T2 | T3 | P for trend | |
---|---|---|---|---|---|
25(OH)D, serum (nmol/L) | |||||
Gender | |||||
Male | 69.49 ± 31.27 | 71.56 ± 31.56 | 68.65 ± 30.26 | 67.58 ± 31.86 | 0.043 |
Female | 72.94 ± 35.21 | 78.54 ± 34.41 | 74.17 ± 37.26 | 67.76 ± 33.14 | < 0.001 |
Low eGFR | |||||
No | 62.17 ± 27.82 | 66.24 ± 28.89 | 61.85 ± 28.16 | 57.76 ± 26.69 | < 0.001 |
Yes | 79.33 ± 35.77 | 83.14 ± 35.56 | 79.96 ± 36.73 | 75.41 ± 34.65 | < 0.001 |
CKD | |||||
Stage 1 | 57.17 ± 24.49 | 60.99 ± 24.68 | 55.46 ± 23.26 | 54.69 ± 25.05 | 0.001 |
Stage 2 | 67.80 ± 30.18 | 71.87 ± 30.0 | 68.94 ± 31.29 | 61.48 ± 28.14 | < 0.001 |
Stage 3 | 79.83 ± 35.46 | 83.31 ± 35.45 | 80.94 ± 36.62 | 75.44 ± 33.87 | < 0.001 |
Stage 4 | 78.59 ± 38.56 | 86.94 ± 40.74 | 71.5 ± 33.88 | 80.94 ± 40.76 | 0.469 |
Stage 5 | 68.57 ± 36.38 | 67.98 ± 26.05 | 73.92 ± 43.82 | 65.46 ± 34.88 | 0.82 |
Age | |||||
< 60 years | 59.69 ± 28.01 | 63.88 ± 28.55 | 58.69 ± 27.46 | 55.76 ± 28.42 | < 0.001 |
> 60 years | 78.07 ± 34.07 | 81.1 ± 33.81 | 78.93 ± 35.55 | 74.09 ± 32.92 | < 0.001 |
Diabetes | |||||
No | 72.66 ± 33.05 | 77.2 ± 32.76 | 72.47 ± 32.81 | 67.93 ± 32.98 | < 0.001 |
Yes | 69.13 ± 33.79 | 70.27 ± 32.89 | 69.87 ± 36.17 | 67.43 ± 32.15 | 0.159 |
T1 the first tertile, T2 the second tertile, T3 the top tertile, CKD chronic kidney disease, Low eGFR: eGFR < 60 ml/min/1.73 m2. CKD stage 1: eGFR ≥ 90 ml/min/1.73 m2 and ACR ≥ 3 mg/mmol; stage 2: 60 ml/min/1.73 m2 ≤ eGFR < 90 ml/min/1.73 m2 and ACR ≥ 3 mg/mmol; stage 3: 30 ml/min/1.73 m2 ≤ eGFR < 60 ml/min/1.73 m2; stage 4: 15 ml/min/1.73 m2 ≤ eGFR < 30 ml/min/1.73 m2; stage 5: eGFR < 15 ml/min/1.73 m2